50
Participants
Start Date
January 1, 2017
Primary Completion Date
March 30, 2018
Study Completion Date
February 28, 2019
Conbercept
Three-port 25-G PPV was performed in all patients using a Constellation system. Patients in the treatment group received an intravitreal injection of conbercept (10 mg/mL, 0.5 mg) using a sterile technique after 25-G vitrectomy.
Tianjin Medical University Eye Hospital
OTHER